Key Insights

Highlights

Success Rate

50% trial completion

Treatment Research

7 treatments under study, led by No Tensing Exercises

Research Leaders

7 sponsors active, led by Lundbeck LLC

Related Conditions

Often studied with 20 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 85/100

Termination Rate

20.0%

1 terminated out of 5 trials

Success Rate

50.0%

-36.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

50% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (3)
Phase 2 (1)

Trial Status

Unknown2
Terminated1
Not Yet Recruiting1
Completed1

Trial Success Rate

50.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (5)

Research Network

Common Treatments

  • No Tensing Exercises1
  • Tensing Exercises1
  • Physical Countermaneuver1
  • Droxidopa1
  • Application Of Ambulatory Cardiac Monitor1

Active Sponsors

  • Lundbeck LLC1
  • University Hospital, Grenoble1
  • University of Calgary1
  • New York Medical College1
  • Etablissement Français du Sang1

Top Investigators

Related Conditions

  • Presyncope3
  • Syncope2
  • Bradycardia1
  • Supraventricular Tachycardia Svt1
  • Atrial Fibrillation Af1

Activity Timeline